ZFunds
For Experts
About Us
Contact Us
Start a Conversation
Portfolio Management Services (PMS)
Compare Schemes
Dezerv Equity Revival Strategy vs Valcreate Lifesciences and Specialty Opportunities
Benchmark
Download PDF
Dezerv Equity Revival Strategy
Valcreate Lifesciences and Specialty Opportunities
Add Scheme
Return for the risk
3Y
1Y
3 yrs return
5%
10%
15%
20%
25%
Nifty 500 · 12.1%
Valcreate Lifesciences and Specialty Opportunities
19.3% • vol 20.7%
10%
20%
30%
Volatility • 3 yrs deviation
Overview
1 Month
0.80%
6.35%
6 Months
2.16%
17.95%
1 Year
5.26%
21.71%
3 Years
13.42%
19.34%
5 Years
—
—
Since Inception
16.57%
19.34%
Fund Age
4 yrs 4 mo
3 yrs 6 mo
AUM
₹7,112.14 Cr
₹18.73 Cr
Outerperformance
Alpha – 1 Year
0.54%
16.99%
Alpha – 3 Years
1.33%
7.25%
Information Ratio – 3 Years
—
0.85
Risk Ratios
Volatility – 1 Year
—
22.22%
Volatility – 3 Years
—
20.72%
Beta – 1 Year
—
0.87
Beta – 3 Years
—
0.89
Sharpe Ratio – 1 Year
—
0.75
Sharpe Ratio – 3 Years
—
0.85
Worst Rolling Year
—
—
Value at Worst Rolling Year
—
—
Deepest Drawdown
—
—
Recovery Period
—
—
Consistency
1-Year Rolling Windows Positive
—
—
Median Rolling Year
—
—
5-Year Rolling Windows Positive
—
—
Portfolio
Market-Cap Mix
—
—
Number of Stocks
—
—
Portfolio P/E
—
—
Top 5 Holdings
—
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fees
Fixed Fee
1.00% / yr
2.50% / yr
Performance Fee / Plan
10% of profit
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
0% / 0% / 0%
0% / 0% / 0%
Let's start a
conversation
Compare this PMS against 3,000+ others with our research desk
Build a long-term portfolio around your goals, not a one-off buy
Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
Zoom Call
Get a Call
Proceed
We will only use these details to contact you about this enquiry. No spam.